Immunosuppressive effects of 1,2 5-dihydroxyvitamin D3 and its analogue calcipotriol on epidermal cells
- 1 April 1994
- journal article
- Published by Wiley in British Journal of Dermatology
- Vol. 130 (4) , 424-431
- https://doi.org/10.1111/j.1365-2133.1994.tb03373.x
Abstract
1,25-Dihydroxyvitamin D3 (1,25(OH)2D3: calcitriol) is the biologically active form of vitamin D. This hormone is a potent immunoregulatory agent. Calcipotriol is a synthetic analogue of 1,25(OH)2D3, with similar receptor binding, and comparable effects on cell proliferation and differentiation, but less potent effects on calcium metabolism. As a step towards understanding the mechanisms by which vitamin D compounds affect T-cell activation by epidermal cells (EC), we assessed the effects of 1,25(OH)2D3 and calcipotriol on the human allogeneic mixed epidermal cell-lymphocyte reaction. All experiments were performed both with 1,25(OH)2D3, and calcipotriol, with similar results. Both compounds had potent immunoinhibitory properties on this model, and enhanced the immunosuppressive effects of cyclosporin A. Using preincubation experiments, we found that pretreatment of EC with 1,25(OH)2D3 resulted in a more pronounced inhibition than preincubation of lymphoid cells. The epidermal targets of this inhibitory effect have been further investigated, using cultures with freshly isolated Langerhans cells (LC) or LC-depleted keratinocytes, separated by an immunomagnetic particle technique. Pretreatment of LC induced a 30% decrease of proliferation, compared with vehicle-treated LC. These calcitriol-pulsed LC did not decrease the proliferation induced by unmodified autologous EC. As expected. LC-depleted keratinocytes failed to stimulate allogeneic lymphocytes. When added to autologous unmodified EC, however, calcitriol-pulsed keratinocytes induced an 85% decrease of proliferation, compared with vehicle-treated keratinocytes. The phenotypic expression of HLA-DR, -DQ, and -DP antigens on EC, assessed by immunoalkaline phosphatase staining, was not modified after a 2-h or 24-h pulse with 1,25(OH)2D3 or calcipotriol. The inhibitory effect of vitamin D compounds on EC was not modified by indomethacin, but was partially reversed by the addition of anti-TGF-β neutralizing antibodies. In conclusion, 1,25(OH)2D3 and calcipotriol may limit the immune response in human skin through decreased antigen presentation, mediated both by a direct effect on LC and indirectly through modulation of the production of cytokines by keratinocytes.Keywords
This publication has 36 references indexed in Scilit:
- Expression of 1,25-Dihydroxyvitamin D3 Receptors in Normal and Psoriatic SkinJournal of Investigative Dermatology, 1991
- Calcipotriol (MC 903): Pharmacokinetics in rats and biological activities of metabolites: A comparative study with 1,25(OH)2D3Biochemical Pharmacology, 1991
- Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC 903)Archives of Dermatology, 1989
- The immunobiology ofvitamin D: William F.C. RigbyImmunology Today, 1988
- Effects of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivoBiochemical Pharmacology, 1988
- The skin: The site of vitamin D3 synthesis and a target tissue for its metabolite 1,25-dihydroxyvitamin D3Steroids, 1987
- Effect of 1α,25-Dihydroxyvitamin D3 on the Morphologic and Biochemical Differentiation of Cultured Human Epidermal Keratinocytes Grown in Serum-Free ConditionsJournal of Investigative Dermatology, 1986
- Neonatal human foreskin keratinocytes produce 1,25-dihydroxyvitamin D3Biochemistry, 1986
- Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: Inhibition of interleukin-2 and augmentation of interleukin-1 productionCellular Immunology, 1986
- Possible Functions of 1α,25-Dihydroxyvitamin D3, an Active Form of Vitamin D3, in the Differentiation and Development of SkinJournal of Investigative Dermatology, 1985